📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

How can controlled human infection models accelerate clinical development and policy pathways for vaccines against Shigella? (2019)

First Author: Giersing B

Attributed to: The immunological basis of susceptibility to nontyphoidal Salmonella bacteraemia among HIV-infected adults in Uganda funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.vaccine.2019.03.036

PubMed Identifier: 31358238

Publication URI: http://europepmc.org/abstract/MED/31358238

Type: Journal Article/Review

Parent Publication: Vaccine

Issue: 34

ISSN: 0264-410X